LNX2

LNX2 is a RING-type E3 ubiquitin ligase that ubiquitinates diverse substrates—including Numb, CD8α, connexin36 (Cx36), and the glycine transporter GlyT2—to regulate Notch signaling, immune receptor trafficking, synaptic transmission, and cell differentiation. Its catalytic RING domain is flanked by two zinc-binding motifs (Zn-RING-Zn), with the N-terminal zinc finger adopting a unique open-circle Cys2His2 fold essential for ligase activity and protein stability; the enzyme dimerizes and catalyzes autoubiquitination through all seven isopeptide linkages (PMID:26451611). LNX2 recruits substrates through its PDZ domains—binding the C-terminal motifs of CD8α, Cx36, CAR, and Caspr4—and promotes their ubiquitination, endocytic internalization, and lysosomal degradation, thereby controlling surface abundance of gap junction channels, glycine transporters, and immune coreceptors (PMID:22045731, PMID:30295974, PMID:31628376). Through ubiquitin-dependent destabilization of Numb, LNX2 fine-tunes Notch pathway activity in contexts ranging from pancreatic exocrine differentiation and osteoclastogenesis to colorectal cancer Wnt/β-catenin signaling and preimplantation blastocyst formation (PMID:26392552, PMID:25712254, PMID:23319804, PMID:36674899).

1. 2005 Medium

   Establishing that LNX2 functions as a PDZ-domain scaffold that physically engages transmembrane protein cytoplasmic tails answered the initial question of how LNX2 recruits binding partners to subcellular sites.

   Evidence Yeast two-hybrid, co-IP, and affinity chromatography mapping the CAR intracellular tail interaction with LNX2

   PMID:15979067

   Open questions at the time

   • No ubiquitination activity demonstrated for CAR
   • Functional consequence of CAR–LNX2 interaction on viral entry or tight junctions not tested
   • Single-lab finding without independent replication
2. 2011 High

   Demonstrating that LNX2 ubiquitinates CD8α and promotes its lysosomal degradation established LNX2 as a bona fide E3 ligase that controls surface receptor turnover through PDZ-mediated substrate recruitment.

   Evidence In vitro ubiquitylation assay, co-IP, flow cytometry, and confocal microscopy in heterologous expression system

   PMID:22045731

   Open questions at the time

   • Physiological relevance in T cells not shown
   • Identity of the ubiquitin chain linkage on CD8α not determined
3. 2013 Medium

   Showing that LNX2 knockdown reduces NOTCH levels and collapses WNT/β-catenin signaling in colorectal cancer cells linked LNX2's ligase activity to a NOTCH–WNT signaling axis in cancer.

   Evidence RNAi knockdown with global gene expression profiling and luciferase reporter assays in CRC cell lines

   PMID:23319804

   Open questions at the time

   • Direct ubiquitination substrate in this context not identified
   • No in vivo tumor model validation
   • Mechanism connecting Notch reduction to TCF7L2/Wnt output not resolved
4. 2014 Medium

   Placing LNX2 downstream of Caspr4 in neuronal differentiation revealed that PDZ-mediated protein interactions channel LNX2 activity into neural progenitor fate decisions.

   Evidence Co-IP, lentiviral knockdown, and epistasis rescue experiments in neurosphere differentiation assays

   PMID:25279559

   Open questions at the time

   • Whether LNX2 ubiquitinates Caspr4 or a downstream target is unknown
   • In vivo brain phenotype not assessed
5. 2015 High

   Crystal structure determination of the Zn-RING-Zn domain, combined with mutagenesis, revealed a unique N-terminal zinc finger fold indispensable for ligase activity and showed that LNX2 ubiquitinates Numb—the key mechanistic link to Notch regulation.

   Evidence X-ray crystallography, in vitro ubiquitination with all linkage types, site-directed mutagenesis, and Numb ubiquitination assay

   PMID:26451611

   Open questions at the time

   • How dimerization is regulated in cells is unknown
   • Structural basis of PDZ-mediated substrate selection not resolved
6. 2015 Medium

   Parallel studies in osteoclast precursors and zebrafish pancreas converged on the same mechanism—LNX2 ubiquitinates Numb to relieve Notch inhibition—demonstrating conservation across tissues and vertebrate species.

   Evidence shRNA knockdown with signaling analysis in bone marrow macrophages (osteoclastogenesis); morpholino/genetic null epistasis with Numb inhibition in zebrafish pancreas

   PMID:25712254 PMID:26392552

   Open questions at the time

   • Zebrafish studies rely on morpholino knockdown of orthologs; mammalian pancreatic phenotype not confirmed
   • Whether LNX2 ubiquitinates Numb isoform-specifically is untested
7. 2018 High

   Identification of connexin36 as an LNX2 substrate at neuronal gap junctions, with ligase-dead mutant controls, extended LNX2's role to ubiquitin-dependent remodeling of electrical synapses.

   Evidence Immunofluorescence colocalization in adult mouse brain, reciprocal co-IP, PDZ2 pull-down, and cotransfection assay with ligase-inactive LNX2

   PMID:30295974

   Open questions at the time

   • Direct ubiquitination of Cx36 not demonstrated with in vitro reconstitution
   • Electrophysiological consequence of LNX2-mediated Cx36 loss not measured
8. 2019 High

   Discovery that LNX2 ubiquitinates the glycine transporter GlyT2 at a defined C-terminal lysine cluster, with genetic knockout validation in spinal cord neurons, established LNX2 as a regulator of inhibitory synaptic glycine reuptake.

   Evidence Unbiased ubiquitination screen, in vitro ubiquitination, lysine mutagenesis, LNX2 KO neurons, and GlyT2 transport assay

   PMID:31628376

   Open questions at the time

   • In vivo behavioral or pain phenotype from LNX2 KO not reported
   • Whether PKC directly phosphorylates LNX2 or GlyT2 to trigger ubiquitination is unresolved
9. 2023 Medium

   Extension of LNX2 function to preimplantation development showed that LNX2 loss impairs blastocyst formation and deregulates Notch and Hippo pathway genes, broadening its developmental role to the earliest cell lineage decisions.

   Evidence siRNA knockdown in mouse embryos with developmental staging and transcript analysis

   PMID:36674899

   Open questions at the time

   • Hippo pathway regulation is inferred from transcriptomics only, no direct substrate identified
   • Rescue experiments not performed

• The structural basis of how LNX2 PDZ domains select among diverse substrates, whether LNX2 catalytic activity is post-translationally regulated, and the in vivo physiological consequences of LNX2 knockout in mammalian brain and immune tissues remain unresolved.
• No full-length LNX2 structure including PDZ domains
• No conditional knockout phenotype reported in mammalian nervous system
• Regulatory inputs (phosphorylation, protein partners controlling LNX2 activity) largely uncharacterized